TNFRSF1A and myelodysplastic syndrome: Notably, IL1A expression was increased in MDS patients compared to health controls, while TNFRSF1A, PPID, PLA2G4A, MLKL, TNFSF10, FAS, JAK2, STAT1, STAT3, IRF9, USP21, and BAX expression levels were decreased.